The piggyBac transposon holds promise for human gene therapy
- 10 October 2006
- journal article
- editorial
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (41) , 14981-14982
- https://doi.org/10.1073/pnas.0607282103
Abstract
Ever since their molecular isolation in eukaryotic organisms, transposons have been precious implements of the geneticist's toolkit. The properties that make transposons so useful are their ability to move from one chromosomal position to another and the relatively minimal requirements for transposition to occur in the test tube and in living cells (1). In particular, transposons can be harnessed to stably integrate sizeable pieces of DNA into a host's chromosome (2, 3). This quality provides a tremendous potential for transgenesis and large-scale insertional mutagenesis. Transposon-mediated DNA delivery, although first limited to a small number of invertebrate species, has become progressively more applicable to vertebrates, including mammalian cells (3–5). This progress has opened the door to the development of a new generation of vectors for human gene therapy and mammalian forward genetics that are potentially more easily controlled, more versatile, and safer than viral vectors (5). However, applications of transposon vectors for clinical trials in gene therapy, and the predictable manipulation of mammalian genomes, have been hindered by their low integration efficiency relative to viral vectors. In this issue of PNAS, Wu et al. (6) move one step further in the quest for a superior gene delivery tool in mammals. They identified piggyBac (PB) as the most active and flexible transposon system yet tested for transformation of mammalian cells. DNA transposons are the most frequently used mobile elements for manipulating and transforming genomes of prokaryotic and eukaryotic organisms. They transpose through a “cut-and-paste” mechanism whereby the transposase (generally encoded by the element) catalyzes the excision of the transposon from one chromosomal site and its reinsertion elsewhere in the genome. This process has two key properties that make DNA transposons very attractive as genetic tools. First, most DNA transposons require only a single protein, the transposase, to transpose both …Keywords
This publication has 27 references indexed in Scilit:
- piggyBac is a flexible and highly active transposon as compared to Sleeping Beauty , Tol2 , and Mos1 in mammalian cellsProceedings of the National Academy of Sciences, 2006
- ChimericMos1andpiggyBactransposases result in site‐directed integrationThe FASEB Journal, 2006
- Sleeping beauty: a novel cancer gene discovery toolHuman Molecular Genetics, 2006
- Sleeping Beauty transposase modulates cell-cycle progression through interaction with Miz-1Proceedings of the National Academy of Sciences, 2006
- Functional zinc finger/sleeping beautytransposase chimeras exhibit attenuated overproduction inhibitionFEBS Letters, 2005
- Site-directed genome modification: derivatives of DNA-modifying enzymes as targeting toolsTrends in Biotechnology, 2005
- NIH open-access plans draw fire from both sidesNature, 2005
- Molecular evolutionary analysis of the widespread piggyBac transposon family and related "domesticated" sequencesMolecular Genetics and Genomics, 2003
- Initial sequencing and analysis of the human genomeNature, 2001
- Genomic regulation of transposable elements in DrosophilaCurrent Opinion in Genetics & Development, 1995